Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 44, Issue 4, 2013, Pages 344-359

  Nunes, Renata Portella ^a,b   Gregori, Giovanni ^a   Yehoshua, Zohar ^a   Stetson, Paul F ^c   Feuer, William ^a   Moshfeghi, Andrew A ^a   Rosenfeld, Philip J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c CARL ZEISS SMT AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

A SCAN; AGED; ARTICLE; AUTOFLUORESCENCE; B SCAN; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GEOGRAPHIC ATROPHY; HUMAN; MALE; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA; RETINA MACULA AGE RELATED DEGENERATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; AGING; CAMERA; CLINICAL EXAMINATION; COLOR; COMPUTER PROGRAM; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; DIAGNOSTIC IMAGING; EYE; EYE FUNDUS; GERIATRIC PATIENT; IMAGE ANALYSIS; IMAGING SYSTEM; MICROCOMPUTER; OPTICAL COHERENCE TOMOGRAPHY; PREDICTION; RETINA MACULA LUTEA; SLIT LAMP; TABLET COMPUTER; METHODOLOGY; PATHOLOGY; RETINA MACULA DEGENERATION; VERY ELDERLY; MACULAR DEGENERATION; PROCEDURES;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GEOGRAPHIC ATROPHY; HUMANS; MACULAR DEGENERATION; MALE; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84881604968     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20130715-06     Document Type: Article

References (44)

1. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012;33:295-317.
2. Sarks SH. Ageing and degeneration in the macular region: a clinicopathological study. Br J Ophthalmol. 1976;60:324-341.
3. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond). 1988;2:552-577.
4. Sunness JS, Bressler NM, Tian Y, Alexander J, Applegate CA. Measuring geographic atrophy in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 1999;40:1761-1769.
5. Sunness JS, Gonzalez-Baron J, Applegate CA, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of agerelated macular degeneration. Ophthalmology. 1999;106:1768-1779.
6. Pumariega NM, Smith RT, Sohrab MA, Letien V, Souied EH. A prospective study of reticular macular disease. Ophthalmology 2011;118:1619-1625.
7. Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology. 2010;117:1775-1781.
8. Sunness JS, Margalit E, Srikumaran D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007;114:271-277.
9. Lindblad AS, Lloyd PC, Clemons TE, et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127:1168-1174.
10. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143:463-472.
11. Yehoshua Z, Rosenfeld PJ, Gregori G, et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology. 2011;118:679-686.
12. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484-1498.
13. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574.
14. Schmitz-Valckenberg S, Alten F, Steinberg JS, et al. Reticular drusen associated with geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:5009-5015.
15. Schmitz-Valckenberg S, Bindewald-Wittich A, Dolar-Szczasny J, et al. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci. 2006;47:2648-2654.
16. Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol. 2009;54:96-117.
17. Fleckenstein M, Schmitz-Valckenberg S, Martens C, et al. Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci. 2011;52:3761-3766.
18. Bearelly S, Chau FY, Koreishi A, Stinnett SS, Izatt JA, Toth CA. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology. 2009;116:1762-1769.
19. Brar M, Kozak I, Cheng L, et al. Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol. 2009;148:439-444.
20. Fleckenstein M, Charbel Issa P, Helb HM, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:4137-4144.
21. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:3846-3852.
22. Schmitz-Valckenberg S, Fleckenstein M, Gobel AP, Hohman TC, Holz FG. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:1-6.
23. Hogan MJ. Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:64-80.
24. Berrow EJ, Bartlett HE, Eperjesi F, Gibson JM. The electroretinogram: a useful tool for evaluating age-related macular disease?. Doc Ophthalmol. 2010;121:51-62.
25. Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS. Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol. 2003;121:1404-1414.
26. Walter P, Widder RA, Luke C, Konigsfeld P, Brunner R. Electrophysiological abnormalities in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237:962-968.
27. Jackson GR, McGwin G, Jr., Phillips JM, Klein R, Owsley C. Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. Invest Ophthalmol Vis Sci. 2004;45:3271-3278.
28. Jackson GR, McGwin G, Jr., Phillips JM, Klein R, Owsley C. Impact of aging and age-related maculopathy on inactivation of the a-wave of the rod-mediated electroretinogram. Vision Res. 2006;46:1422-1431.
29. Feigl B, Brown B, Lovie-Kitchin J, Swann P. The rod-mediated multifocal electroretinogram in aging and in early age-related maculopathy. Curr Eye Res. 2006;31:635-644.
30. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Cone-mediated multifocal electroretinogram in early age-related maculopathy and its relationships with subjective macular function tests. Curr Eye Res. 2004;29:327-336.
31. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy. Eye (Lond). 2005;19:431-441.
32. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Monitoring retinal function in early age-related maculopathy: visual performance after 1 year. Eye (Lond). 2005;19:1169-1177.
33. Gin TJ, Luu CD, Guymer RH. Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:9267-9274.
34. Parisi V, Perillo L, Tedeschi M, et al. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration. Retina. 2007;27:879-890.
35. Sunness JS, Johnson MA, Massof RW, Marcus S. Retinal sensitivity over drusen and nondrusen areas. A study using fundus perimetry. Arch Ophthalmol. 1988;106:1081-1084.
36. Sunness JS, Schuchard RA, Shen N, Rubin GS, Dagnelie G, Haselwood DM. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci. 1995;36:1863-1874.
37. Meleth AD, Mettu P, Agron E, et al. Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry. Invest Ophthalmol Vis Sci. 2011;52:1119-1126.
38. Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol. 2007;91:1499-1503.
39. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:3355-3360.
40. Luu CD, Dimitrov PN, Robman L, et al. Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration. Arch Ophthalmol. 2012;130:690-699.
41. Sunness JS, Rubin GS, Broman A, Applegate CA, Bressler NM, Hawkins BS. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115:1480-1488, 1488 e1481-1482.
42. Csaky KG, Richman EA, Ferris FL, 3rd. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci. 2008;49:479-489.
43. Yehoshua Z, Rosenfeld PJ, Albini TA. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures. Semin Ophthalmol. 2011;26:167-180.
44. Sallo FB, Peto T, Egan C, et al. "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2012;53:6145-6152.